Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bielack

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP C W Hogendoorn, , N Athanasou, et al.
Pediatric Blood & Cancer|July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcomaPeter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Claudia Blattmann, Arndt Borkhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adultsTobias M Dantonello, Christoph Int-Veen, Dieter Harms, et al.
ESMO Open|April 30, 2021
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)A Ferrari, D Stark, F A Peccatori, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Klinische Padiatrie|September 3, 1999
[Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]S Bielack, B Kempf-Bielack, D Schwenzer, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2019
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2020
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusionS S Bielack, M C Cox, M Nathrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP C W Hogendoorn, , N Athanasou, et al.
Pediatric Blood & Cancer|July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcomaPeter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Claudia Blattmann, Arndt Borkhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adultsTobias M Dantonello, Christoph Int-Veen, Dieter Harms, et al.
ESMO Open|April 30, 2021
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)A Ferrari, D Stark, F A Peccatori, et al.
Pediatric Blood & Cancer|June 6, 2013
Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and AustriaC Rossig, H Juergens, M Schrappe, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Klinische Padiatrie|September 3, 1999
[Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]S Bielack, B Kempf-Bielack, D Schwenzer, et al.
Pageof 19